Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism DLL1 inhibitors(delta like canonical Notch ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hormone receptor positive breast cancer | Preclinical | PT | 13 Aug 2021 |